<DOC>
	<DOCNO>NCT01430104</DOCNO>
	<brief_summary>The purpose trial ass effect serum calcium teriparatide use active vitamin D osteoporosis patient . This study consist Screening Period , 14-day Lead-in Period , 28-day Treatment Period , 7-day Follow-up Period . Patients take vitamin D calcium supplementation Lead-in Period throughout study . During Treatment Period , daily administration teriparatide add .</brief_summary>
	<brief_title>A Study Teriparatide Japanese Osteoporosis Patients</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Ambulatory Japanese male postmenopausal female osteoporosis , determine Japanese Society Bone Mineral Research ( JSBMR ) diagnostic criterion Prior treatment parathyroid hormone ( PTH ) PTH analog History metabolic bone disorder primary osteoporosis Fractures cause disease osteoporosis Abnormal thyroid function Hyperparathyroidism hypoparathyroidism Severe chronically disable condition osteoporosis Currently history spruce , inflammatory bowel disease , malabsorption syndrome Currently , history , nephrolithiasis urolithiasis 2 year prior screen Clinically significant abnormal laboratory value electrocardiogram Treatment oral bisphosphonates time 3 month prior enrollment , treatment bisphosphonate 60 day 6 month prior enrollment , intravenous bisphosphonates time 24 month prior enrollment ; case oral bisphosphonates administer week , equivalent Treatment injectable calcitonin 3 month prior enrollment Treatment raloxifene hydrochloride 3 month 6 month prior enrollment Treatment systemic corticosteroid , except orally inhale nasally inhaled corticosteroid , dos &lt; = 800 microgram per day ( Âµg/day ) beclomethasone dipropionate equivalent 3 month prior screen , 30 day 12 month prior enrollment Treatment anticonvulsant , except benzodiazepine , 6 month prior enrollment Prior treatment strontiumranate denosumab ( antiRANKL antibody ) Prior external beam radiation therapy involve skeleton Current history malignant neoplasm 5 year prior screen , exception superficial basal cell carcinoma squamous cell carcinoma skin definitively treat</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>